Pediatric Hematology-Oncology Trials:​ Successful Novel Therapeutic Strategies​

Despite significant progress in pediatric clinical research, childhood cancer remains a leading cause of death among children. Continued research is crucial for developing new treatments that improve survival rates and outcomes. However, pediatric cancer clinical trials encounter many challenges, especially within today’s clinical drug development landscape. These include the need for targeted therapies for children, regulatory delays, design constraints, and gaps in representation and equity within current clinical trial research. Conversely, cooperative groups in the US and Europe have strong infrastructure for clinical trials, but expanding studies to regions with higher rates of pediatric cancers and limited treatment options poses a major obstacle.

This webinar addresses these key challenges in advanced therapies, including gene and cellular therapies, while offering different and innovative approaches that can be put into practice, enabling future clinical trials to avoid enrollment challenges and delays in study timelines. Ultimately, this results in the best chance for clinical trial success and better outcomes for patients.